Evidence mapPaperPMID 26109865Full record

ReviewVascular health and risk management2015

Lipidomics in vascular health: current perspectives.

Genovefa Kolovou, Vana Kolovou, Sophie Mavrogeni

Open access · goldAbstract readReview
In one paragraph

Review in Vascular health and risk management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Occult hypoperfusion and changes of systemic lipid levels after severe trauma: an analysis in a standardized porcine polytrauma model.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Article
  3. Review
  4. Review
  5. The Lipidome Fingerprint of Longevity.Molecules (Basel, Switzerland) · 2020
    Review
  6. Article
  7. Article
  8. Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Lipidomics for studying metabolism.Nature reviews. Endocrinology · 2016
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Genovefa KolovouCardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.
Vana KolovouCardiology Department, Onassis Cardiac Surgery Center, Athens, Greece ; Molecular Immunology Laboratory, Onassis Cardiac Surgery Center, Athens, Greece.
Sophie MavrogeniCardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.
Institute of Cardiology · PLOnassis Cardiac Surgery Center · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying the mechanisms that convert a healthy vascular wall to an atherosclerotic wall is of major importance since the consequences may lead to a shortened lifespan. Classical risk factors (age, smoking, obesity, diabetes mellitus, hypertension, and dyslipidemia) may result in the progression of atherosclerotic lesions by processes including inflammation and lipid accumulation. Thus, the evaluation of blood lipids and the full lipid complement produced by cells, organisms, or tissues (lipidomics) is an issue of importance. In this review, we shall describe the recent progress in vascular health research using lipidomic advances. We will begin with an overview of vascular wall biology and lipids, followed by a short analysis of lipidomics. Finally, we shall focus on the clinical implications of lipidomics and studies that have examined lipidomic approaches and vascular health.

Indexed as

Lipid MetabolismAtherosclerosisBiomarkersHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsLipoproteinsPlaque, AtheroscleroticRisk FactorsBiomarkersHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsLipoproteinsatherosclerosislipidomicslipidsmass spectrometryvascular

Identifiers

PMID26109865
PMCPMC4472029
OpenAlexW1563835712

What Socratic holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.